Zobrazeno 1 - 10
of 439
pro vyhledávání: '"Myocardial biopsy"'
Autor:
Hiromi Miwa, Naoki Hayakawa, Yasuyuki Tsuchida, Shinya Ichihara, Satoshi Hirano, Shunsuke Maruta, Kotaro Miyaji, Shunichi Kushida
Publikováno v:
CVIR Endovascular, Vol 7, Iss 1, Pp 1-6 (2024)
Abstract Background Hemostatic devices are now frequently used in femoral artery punctures, and the Angio-Seal (Terumo, Tokyo, Japan) is one of the most commonly used devices for closure of the femoral artery because it provides rapid hemostasis. Alt
Externí odkaz:
https://doaj.org/article/780715e7087d466798750f4469036625
Autor:
Kei Morishita, MD, Katsuhito Fujiu, MD, PhD, Kenichiro Yamagata, MD, PhD, Eisuke Amiya, MD, PhD, Norihiko Takeda, MD, PhD
Publikováno v:
HeartRhythm Case Reports, Vol 10, Iss 9, Pp 635-638 (2024)
Externí odkaz:
https://doaj.org/article/6b15dd9c895142219e9c6772504ae99f
Publikováno v:
Radiology Case Reports, Vol 18, Iss 6, Pp 2103-2106 (2023)
Cardiac cysticercosis is rare in clinical practice and is usually accidentally identified during cardiac surgery or autopsies. Although mostly asymptomatic, cardiac cysticercosis could present with severe clinical conditions such as myocarditis, acut
Externí odkaz:
https://doaj.org/article/d43d06ad2d864fb08baf670bf441fe3d
Autor:
Yu. A. Lutokhina, O. V. Blagova, E. A. Kogan, A. A. Nartov, V. R. Nartova, E. V. Zaklyazminskaya, S. L. Dzemeshkevich
Publikováno v:
Российский кардиологический журнал, Vol 28, Iss 11 (2023)
Aim. To assess the incidence of myocarditis in patients with primary myocardial hypertrophy and to study its contribution to the disease course.Material and methods. The study included 100 patients with primary left ventricular myocardial hypertrophy
Externí odkaz:
https://doaj.org/article/b7143c25195148e299d9aa73efece401
Autor:
A. M. Osadchy, I. A. Makarov, A. V. Skoptsova, L. B. Mitrofanova, A. V. Kamenev, S. G. Shcherbak, D. S. Lebedev
Publikováno v:
Российский кардиологический журнал, Vol 28, Iss 9 (2023)
Arrhythmias occur both in the acute coronavirus disease 2019 (COVID-19) and in the post-acute period, which may be associated with the long-term SARS-CoV-2 persistence. In a case report, patient with primary dilated cardiomyopathy, an implanted cardi
Externí odkaz:
https://doaj.org/article/da1cc49d0cfb49129ee7b617848ec361
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Tetsuya Nomura, Issei Ota, Satoshi Tasaka, Kenshi Ono, Yu Sakaue, Keisuke Shoji, Naotoshi Wada
Publikováno v:
CVIR Endovascular, Vol 5, Iss 1, Pp 1-5 (2022)
Abstract Background Despite marked progress in endovascular treatment (EVT) techniques and devices, calcified lesions remain one of the toughest obstacles to EVT success. Moreover, because the common femoral artery (CFA) is known as a “non-stenting
Externí odkaz:
https://doaj.org/article/99effc1f3879449fb82ab92c5341e085
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Vascular Health and Risk Management, Vol Volume 17, Pp 661-673 (2021)
Grigorios Korosoglou,1,2 Sorin Giusca,1,2 Florian André,3,4 Fabian aus dem Siepen,3,4 Peter Nunninger,5 Arnt V Kristen,3,6 Norbert Frey3,4 1GRN Hospital Weinheim, Department of Cardiology, Vascular Medicine and Pneumology, Weinheim, Germany; 2Cardia
Externí odkaz:
https://doaj.org/article/e08f48091d744fd6b177ae65a263739a
Autor:
Kei Kunimasa, MD, PhD, Risa Kamada, MD, Toru Oka, MD, PhD, Makiko Oboshi, MD, PhD, Madoka Kimura, MD, Takako Inoue, MD, Motohiro Tamiya, MD, Tatsuya Nishikawa, MD, PhD, Taku Yasui, MD, PhD, Wataru Shioyama, MD, PhD, Kazumi Nishino, MD, PhD, Fumio Imamura, MD, PhD, Toru Kumagai, MD, PhD, Masashi Fujita, MD, PhD
Publikováno v:
JACC. CardioOncology, Vol 2, Iss 1, Pp 1-10 (2020)
Objectives: The purpose of this study was to assess osimertinib-associated cardiac adverse events (AEs) in a real-world setting, using a retrospective single-center cohort study in Japan. Background: Cases of osimertinib-associated cardiac AEs have b
Externí odkaz:
https://doaj.org/article/cd084dc47bf644bfa229ea9866542e66